WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care ...

TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025 TriSalus Life Sciences, Inc. (Nasdaq: TLSI) ...

WESTMINSTER, Colo., November 18, 2025--(BUSINESS WIRE)--TriSalus Life Sciences, an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for ...

TriSalus Life Sciences, an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors, is pleased to announce the ...

The Cyrus CDi has an enviable record: this year, it has won an astonishing 12 consecutive What Hi-Fi? Award trophies in a row. That is undoubtedly impressive, but this feat alone isn’t enough to ...

This long-running, multiple Award-winning Cyrus CD player remains a firm favourite for its excellent sound and reliable functionality. Why you can trust What Hi-Fi? Our expert team reviews products in ...

WESTMINSTER, Colo. - TriSalus Life Sciences Inc. (NASDAQ:TLSI), a $149.46 million market cap medical technology company, announced clinical data showing its Pressure-Enabled Drug Delivery technology ...

The TriNav FLX Infusion System is designed to offer improved navigation through complex vascular structures, featuring a more flexible distal end. According to the company, this flexibility ...

(RTTNews) - TriSalus Life Sciences, Inc. (TLSI) has unveiled the TriNav FLX Infusion System, a new addition to its TriNav portfolio. The latest system enhances trackability and flexibility, allowing ...

DENVER--(BUSINESS WIRE)-- TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), which seeks to transform outcomes for patients with solid tumors by integrating our innovative ...